| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer.
|
Int J Radiat Oncol Biol Phys
|
2007
|
6.98
|
|
2
|
Cyclin E and survival in patients with breast cancer.
|
N Engl J Med
|
2002
|
6.44
|
|
3
|
Radiation dose-volume effects in radiation-induced rectal injury.
|
Int J Radiat Oncol Biol Phys
|
2010
|
3.83
|
|
4
|
Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system.
|
Int J Radiat Oncol Biol Phys
|
2004
|
3.21
|
|
5
|
Increased risk of biochemical and local failure in patients with distended rectum on the planning CT for prostate cancer radiotherapy.
|
Int J Radiat Oncol Biol Phys
|
2005
|
3.19
|
|
6
|
Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT).
|
Int J Radiat Oncol Biol Phys
|
2006
|
2.82
|
|
7
|
Single nucleotide polymorphism at rs1982073:T869C of the TGFbeta 1 gene is associated with the risk of radiation pneumonitis in patients with non-small-cell lung cancer treated with definitive radiotherapy.
|
J Clin Oncol
|
2009
|
2.75
|
|
8
|
Prescribing radiation dose to lung cancer patients based on personalized toxicity estimates.
|
J Thorac Oncol
|
2012
|
2.61
|
|
9
|
Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy.
|
Int J Radiat Oncol Biol Phys
|
2007
|
2.28
|
|
10
|
Changes in the 2003 American Joint Committee on Cancer staging for breast cancer dramatically affect stage-specific survival.
|
J Clin Oncol
|
2003
|
2.19
|
|
11
|
Lymphovascular invasion and lobular histology are associated with increased incidence of isolated tumor cells in sentinel lymph nodes from early-stage breast cancer patients.
|
Ann Surg Oncol
|
2008
|
2.17
|
|
12
|
Chemotherapy-induced apoptosis and Bcl-2 levels correlate with breast cancer response to chemotherapy.
|
Cancer J
|
2003
|
2.11
|
|
13
|
Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity.
|
Clin Cancer Res
|
2005
|
2.09
|
|
14
|
Cytokines in pancreatic carcinoma: correlation with phenotypic characteristics and prognosis.
|
Cancer
|
2004
|
2.02
|
|
15
|
Influence of technologic advances on outcomes in patients with unresectable, locally advanced non-small-cell lung cancer receiving concomitant chemoradiotherapy.
|
Int J Radiat Oncol Biol Phys
|
2009
|
2.01
|
|
16
|
Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer.
|
Int J Radiat Oncol Biol Phys
|
2004
|
1.94
|
|
17
|
Vorinostat, a histone deacetylase inhibitor, enhances the response of human tumor cells to ionizing radiation through prolongation of gamma-H2AX foci.
|
Mol Cancer Ther
|
2006
|
1.84
|
|
18
|
Mortality risk from squamous cell skin cancer.
|
J Clin Oncol
|
2005
|
1.74
|
|
19
|
Assessment of gross tumor volume regression and motion changes during radiotherapy for non-small-cell lung cancer as measured by four-dimensional computed tomography.
|
Int J Radiat Oncol Biol Phys
|
2007
|
1.74
|
|
20
|
Tumor-specific low molecular weight forms of cyclin E induce genomic instability and resistance to p21, p27, and antiestrogens in breast cancer.
|
Cancer Res
|
2004
|
1.70
|
|
21
|
Estrogen/progesterone receptor negativity and HER2 positivity predict locoregional recurrence in patients with T1a,bN0 breast cancer.
|
Int J Radiat Oncol Biol Phys
|
2010
|
1.67
|
|
22
|
Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery.
|
Int J Radiat Oncol Biol Phys
|
2005
|
1.63
|
|
23
|
Even low-level HER2 expression may be associated with worse outcome in node-positive breast cancer.
|
Am J Surg Pathol
|
2009
|
1.59
|
|
24
|
Feasibility of using intensity-modulated radiotherapy to improve lung sparing in treatment planning for distal esophageal cancer.
|
Radiother Oncol
|
2005
|
1.53
|
|
25
|
Pathologic tumor size and lymph node status predict for different rates of locoregional recurrence after mastectomy for breast cancer patients treated with neoadjuvant versus adjuvant chemotherapy.
|
Int J Radiat Oncol Biol Phys
|
2002
|
1.51
|
|
26
|
T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy.
|
Int J Radiat Oncol Biol Phys
|
2004
|
1.51
|
|
27
|
Candidate dosimetric predictors of long-term swallowing dysfunction after oropharyngeal intensity-modulated radiotherapy.
|
Int J Radiat Oncol Biol Phys
|
2010
|
1.49
|
|
28
|
Postoperative pulmonary complications after preoperative chemoradiation for esophageal carcinoma: correlation with pulmonary dose-volume histogram parameters.
|
Int J Radiat Oncol Biol Phys
|
2003
|
1.45
|
|
29
|
Dose-volume thresholds and smoking status for the risk of treatment-related pneumonitis in inoperable non-small cell lung cancer treated with definitive radiotherapy.
|
Radiother Oncol
|
2008
|
1.40
|
|
30
|
Long-term clinical outcome of intensity-modulated radiotherapy for inoperable non-small cell lung cancer: the MD Anderson experience.
|
Int J Radiat Oncol Biol Phys
|
2011
|
1.37
|
|
31
|
International prognostic index-based outcomes for diffuse large B-cell lymphomas.
|
Cancer
|
2002
|
1.36
|
|
32
|
Factors predictive of distant metastases in patients with breast cancer who have a pathologic complete response after neoadjuvant chemotherapy.
|
J Clin Oncol
|
2005
|
1.33
|
|
33
|
Combined use of clinical and pathologic staging variables to define outcomes for breast cancer patients treated with neoadjuvant therapy.
|
J Clin Oncol
|
2007
|
1.32
|
|
34
|
Risk factors for pericardial effusion in inoperable esophageal cancer patients treated with definitive chemoradiation therapy.
|
Int J Radiat Oncol Biol Phys
|
2008
|
1.32
|
|
35
|
American College of Surgeons Oncology Group (ACOSOG) Z0011: impact on surgeon practice patterns.
|
Ann Surg Oncol
|
2012
|
1.29
|
|
36
|
Intensity-modulated radiation therapy after hysterectomy: comparison with conventional treatment and sensitivity of the normal-tissue-sparing effect to margin size.
|
Int J Radiat Oncol Biol Phys
|
2005
|
1.29
|
|
37
|
Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy.
|
J Clin Oncol
|
2004
|
1.25
|
|
38
|
Predictors of local-regional recurrence after neoadjuvant chemotherapy and mastectomy without radiation.
|
J Clin Oncol
|
2002
|
1.20
|
|
39
|
African-American race is associated with a poorer overall survival rate for breast cancer patients treated with mastectomy and doxorubicin-based chemotherapy.
|
Cancer
|
2006
|
1.20
|
|
40
|
Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiotherapy.
|
Int J Radiat Oncol Biol Phys
|
2005
|
1.20
|
|
41
|
Investigation of bladder dose and volume factors influencing late urinary toxicity after external beam radiotherapy for prostate cancer.
|
Int J Radiat Oncol Biol Phys
|
2007
|
1.17
|
|
42
|
Postmastectomy radiation improves the outcome of patients with locally advanced breast cancer who achieve a pathologic complete response to neoadjuvant chemotherapy.
|
Int J Radiat Oncol Biol Phys
|
2007
|
1.17
|
|
43
|
Evidence of haplotype insufficiency in human cells containing a germline mutation in BRCA1 or BRCA2.
|
Int J Cancer
|
2002
|
1.16
|
|
44
|
Local-regional control according to surrogate markers of breast cancer subtypes and response to neoadjuvant chemotherapy in breast cancer patients undergoing breast conserving therapy.
|
Breast Cancer Res
|
2012
|
1.16
|
|
45
|
Osteoradionecrosis and radiation dose to the mandible in patients with oropharyngeal cancer.
|
Int J Radiat Oncol Biol Phys
|
2012
|
1.13
|
|
46
|
Effects of radiotherapy and chemotherapy on lung function in patients with non-small-cell lung cancer.
|
Int J Radiat Oncol Biol Phys
|
2003
|
1.12
|
|
47
|
Characterization of rectal normal tissue complication probability after high-dose external beam radiotherapy for prostate cancer.
|
Int J Radiat Oncol Biol Phys
|
2004
|
1.11
|
|
48
|
Dosimetric comparison of four target alignment methods for prostate cancer radiotherapy.
|
Int J Radiat Oncol Biol Phys
|
2006
|
1.09
|
|
49
|
Assessment of histologic features and expression of biomarkers in predicting pathologic response to anthracycline-based neoadjuvant chemotherapy in patients with breast carcinoma.
|
Cancer
|
2002
|
1.07
|
|
50
|
Ten-year recurrence rates in young women with breast cancer by locoregional treatment approach.
|
Int J Radiat Oncol Biol Phys
|
2008
|
1.07
|
|
51
|
Low molecular weight cyclin E is specific in breast cancer and is associated with mechanisms of tumor progression.
|
Cell Cycle
|
2009
|
1.06
|
|
52
|
The predictive value of 2-year posttreatment biopsy after prostate cancer radiotherapy for eventual biochemical outcome.
|
Int J Radiat Oncol Biol Phys
|
2006
|
1.04
|
|
53
|
Locoregional recurrence after doxorubicin-based chemotherapy and postmastectomy: Implications for breast cancer patients with early-stage disease and predictors for recurrence after postmastectomy radiation.
|
Int J Radiat Oncol Biol Phys
|
2003
|
1.04
|
|
54
|
Correlation of gross tumor volume excursion with potential benefits of respiratory gating.
|
Int J Radiat Oncol Biol Phys
|
2004
|
1.04
|
|
55
|
Risk factors for acute esophagitis in non-small-cell lung cancer patients treated with concurrent chemotherapy and three-dimensional conformal radiotherapy.
|
Int J Radiat Oncol Biol Phys
|
2006
|
1.04
|
|
56
|
The relationship between local dose and loss of function for irradiated lung.
|
Int J Radiat Oncol Biol Phys
|
2003
|
1.03
|
|
57
|
Staging of breast cancer in the neoadjuvant setting.
|
Cancer Res
|
2008
|
1.03
|
|
58
|
Validation of a novel staging system for disease-specific survival in patients with breast cancer treated with neoadjuvant chemotherapy.
|
J Clin Oncol
|
2011
|
1.02
|
|
59
|
Low-molecular-weight cyclin E can bypass letrozole-induced G1 arrest in human breast cancer cells and tumors.
|
Clin Cancer Res
|
2010
|
1.01
|
|
60
|
Dose-response characteristics of low- and intermediate-risk prostate cancer treated with external beam radiotherapy.
|
Int J Radiat Oncol Biol Phys
|
2005
|
1.00
|
|
61
|
Quantification of prostate and seminal vesicle interfraction variation during IMRT.
|
Int J Radiat Oncol Biol Phys
|
2008
|
0.99
|
|
62
|
Predictors of postoperative complications after trimodality therapy for esophageal cancer.
|
Int J Radiat Oncol Biol Phys
|
2013
|
0.99
|
|
63
|
Proton beam craniospinal irradiation reduces acute toxicity for adults with medulloblastoma.
|
Int J Radiat Oncol Biol Phys
|
2013
|
0.99
|
|
64
|
Impact of chemotherapy sequencing on local-regional failure risk in breast cancer patients undergoing breast-conserving therapy.
|
Ann Surg
|
2013
|
0.97
|
|
65
|
Paget's disease of the breast: there is a role for breast-conserving therapy.
|
Ann Surg Oncol
|
2005
|
0.95
|
|
66
|
Cyclin E is a more powerful predictor of breast cancer outcome than proliferation.
|
Nat Med
|
2003
|
0.94
|
|
67
|
Outcome of salvage radiotherapy for biochemical failure after radical prostatectomy with or without hormonal therapy.
|
Int J Radiat Oncol Biol Phys
|
2005
|
0.93
|
|
68
|
Intrathoracic patterns of failure for non-small-cell lung cancer with positron-emission tomography/computed tomography-defined target delineation.
|
Int J Radiat Oncol Biol Phys
|
2007
|
0.93
|
|
69
|
Use of 4-dimensional computed tomography-based ventilation imaging to correlate lung dose and function with clinical outcomes.
|
Int J Radiat Oncol Biol Phys
|
2013
|
0.93
|
|
70
|
Coexpression of alpha6beta4 integrin and guanine nucleotide exchange factor Net1 identifies node-positive breast cancer patients at high risk for distant metastasis.
|
Cancer Epidemiol Biomarkers Prev
|
2009
|
0.93
|
|
71
|
An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin disease.
|
Cancer
|
2002
|
0.92
|
|
72
|
Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non-small-cell lung cancer: report of a randomized comparative trial.
|
Int J Radiat Oncol Biol Phys
|
2004
|
0.91
|
|
73
|
Dose-response for biochemical control among high-risk prostate cancer patients after external beam radiotherapy.
|
Int J Radiat Oncol Biol Phys
|
2003
|
0.91
|
|
74
|
Influence of preoperative radiation field on postoperative leak rates in esophageal cancer patients after trimodality therapy.
|
J Thorac Oncol
|
2014
|
0.90
|
|
75
|
Statistical assessment of proton treatment plans under setup and range uncertainties.
|
Int J Radiat Oncol Biol Phys
|
2013
|
0.90
|
|
76
|
Predictors of high-grade esophagitis after definitive three-dimensional conformal therapy, intensity-modulated radiation therapy, or proton beam therapy for non-small cell lung cancer.
|
Int J Radiat Oncol Biol Phys
|
2012
|
0.89
|
|
77
|
Assessing the impact of an alternative biochemical failure definition on radiation dose response for high-risk prostate cancer treated with external beam radiotherapy.
|
Int J Radiat Oncol Biol Phys
|
2005
|
0.89
|
|
78
|
A technique to use CT images for in vivo detection and quantification of the spatial distribution of radiation-induced esophagitis.
|
J Appl Clin Med Phys
|
2013
|
0.87
|
|
79
|
Low molecular weight cyclin E is associated with p27-resistant, high-grade, high-stage and invasive bladder cancer.
|
Cell Cycle
|
2012
|
0.86
|
|
80
|
Prospective analysis of carotid artery flow in breast cancer patients treated with supraclavicular irradiation 8 or more years previously: no increase in ipsilateral carotid stenosis after radiation noted.
|
Cancer
|
2008
|
0.85
|
|
81
|
Association between systemic chemotherapy before chemoradiation and increased risk of treatment-related pneumonitis in esophageal cancer patients treated with definitive chemoradiotherapy.
|
J Thorac Oncol
|
2008
|
0.85
|
|
82
|
Dosimetric benefits of respiratory gating: a preliminary study.
|
J Appl Clin Med Phys
|
2004
|
0.84
|
|
83
|
A volumetric trend analysis of the prostate and seminal vesicles during a course of intensity-modulated radiation therapy.
|
Am J Clin Oncol
|
2010
|
0.84
|
|
84
|
Is a 3-mm intrafractional margin sufficient for daily image-guided intensity-modulated radiation therapy of prostate cancer?
|
Radiother Oncol
|
2007
|
0.83
|
|
85
|
First-year PSA kinetics and minima after prostate cancer radiotherapy are predictive of overall survival.
|
Int J Radiat Oncol Biol Phys
|
2006
|
0.82
|
|
86
|
The delivery of IMRT with a single physical modulator for multiple fields: a feasibility study for paranasal sinus cancer.
|
Int J Radiat Oncol Biol Phys
|
2004
|
0.82
|
|
87
|
Changes in the pelvic anatomy after an IMRT treatment fraction of prostate cancer.
|
Int J Radiat Oncol Biol Phys
|
2007
|
0.82
|
|
88
|
Cyclin E-associated kinase activity predicts response to platinum-based chemotherapy.
|
Clin Cancer Res
|
2007
|
0.81
|
|
89
|
Impact of p210(Bcr-Abl) on ultraviolet C wavelength-induced DNA damage and repair.
|
Clin Cancer Res
|
2003
|
0.81
|
|
90
|
Stage III follicular lymphoma: long-term follow-up and patterns of failure.
|
Int J Radiat Oncol Biol Phys
|
2003
|
0.80
|
|
91
|
Cluster models of dose-volume effects.
|
Int J Radiat Oncol Biol Phys
|
2004
|
0.79
|
|
92
|
Evaluation of the MD Anderson Prognostic Index for local-regional recurrence after breast conserving therapy in patients receiving neoadjuvant chemotherapy.
|
Ann Surg Oncol
|
2011
|
0.79
|
|
93
|
Urethral pain among prostate cancer survivors 1 to 14 years after radiation therapy.
|
Int J Radiat Oncol Biol Phys
|
2013
|
0.79
|
|
94
|
Technique, outcomes, and acute toxicities in adults treated with proton beam craniospinal irradiation.
|
Neuro Oncol
|
2013
|
0.79
|
|
95
|
Breast cancer patients with 10 or more involved axillary lymph nodes treated by multimodality therapy: influence of clinical presentation on outcome.
|
Int J Radiat Oncol Biol Phys
|
2007
|
0.79
|
|
96
|
TGFβ1 Polymorphisms Predict Distant Metastasis-Free Survival in Patients with Inoperable Non-Small-Cell Lung Cancer after Definitive Radiotherapy.
|
PLoS One
|
2013
|
0.78
|
|
97
|
A novel method to incorporate the spatial location of the lung dose distribution into predictive radiation pneumonitis modeling.
|
Int J Radiat Oncol Biol Phys
|
2011
|
0.78
|
|
98
|
Dosimetric uncertainties of three-dimensional dose reconstruction from two-dimensional data in a multi-institutional study.
|
J Appl Clin Med Phys
|
2004
|
0.78
|
|
99
|
A method to estimate composite doses for organs at risk in prostate cancer patients treated with EBRT in combination with HDR BT.
|
Acta Oncol
|
2014
|
0.78
|
|
100
|
Combining Clinical and Pathologic Staging Variables Has Prognostic Value in Predicting Local-regional Recurrence Following Neoadjuvant Chemotherapy for Breast Cancer.
|
Ann Surg
|
2016
|
0.77
|
|
101
|
Analysis of in-field control and late toxicity for adults with early-stage Hodgkin's disease treated with chemotherapy followed by radiotherapy.
|
Int J Radiat Oncol Biol Phys
|
2003
|
0.77
|
|
102
|
Central lymphatic irradiation for stage I-III follicular lymphoma: report from a single-institutional prospective study.
|
Int J Radiat Oncol Biol Phys
|
2003
|
0.76
|
|
103
|
Occult axillary lymph node metastases do not have prognostic significance in early stage breast cancer.
|
Cancer
|
2011
|
0.76
|
|
104
|
Modulation of rodent spinal cord radiation tolerance by administration of platelet-derived growth factor.
|
Int J Radiat Oncol Biol Phys
|
2004
|
0.76
|
|
105
|
Investigation of the relationship between gross tumor volume location and pneumonitis rates using a large clinical database of non-small-cell lung cancer patients.
|
Int J Radiat Oncol Biol Phys
|
2011
|
0.75
|
|
106
|
Balancing radiation pneumonitis versus locoregional tumor control in non-small-cell lung cancer.
|
J Thorac Oncol
|
2013
|
0.75
|
|
107
|
Daily bone alignment with limited repeat CT correction rivals daily ultrasound alignment for prostate radiotherapy.
|
Int J Radiat Oncol Biol Phys
|
2008
|
0.75
|
|
108
|
Results with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone followed by radiotherapy with or without prechemotherapy surgical debulking for patients with bulky, aggressive lymphoma.
|
Cancer
|
2002
|
0.75
|
|
109
|
Patients with only 1 positive hormone receptor have increased locoregional recurrence compared with patients with estrogen receptor-positive progesterone receptor-positive disease in very early stage breast cancer.
|
Cancer
|
2010
|
0.75
|
|
110
|
Application of the electron pencil beam redefinition algorithm to electron arc therapy.
|
Med Phys
|
2006
|
0.75
|
|
111
|
Learning anatomy changes from patient populations to create artificial CT images for voxel-level validation of deformable image registration.
|
J Appl Clin Med Phys
|
2016
|
0.75
|
|
112
|
Nasopharyngeal cancer in the Middle East: experience of the American University of Beirut Medical Center.
|
Int J Radiat Oncol Biol Phys
|
2005
|
0.75
|
|
113
|
Molecular response of follicular lymphoma to cyclophosphamide, doxorubicin, vincristine, prednisone C(H)OP or COP-based therapy as measured by polymerase chain reaction evidence of translocation (14;18)(q32;q21).
|
Cancer J
|
2004
|
0.75
|
|
114
|
A prospective randomized study to compare the molecular response rates between central lymphatic irradiation and intensive alternating triple chemotherapy in the treatment of stage I-III follicular lymphoma.
|
Int J Radiat Oncol Biol Phys
|
2005
|
0.75
|